FY2025 Annual Report

Reporting period: 2025.01.01-2025.12.31

Summary: SINOTAUPHARMA-B (09941) reported Revenue of 99.21M(+125.15%); Net profit attributable to owners of -610.60M(-309.01%).

ReportedYoY
Prior YearYoY
RevenueUp YoY
99.21M125.15%
44.06M--
Net profit attributable to ownersDown YoY
-610.60M309.01%
-149.29M--

Revenue

ReportedUnit: CNY

Net profit attributable to owners

ReportedUnit: CNY

Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.

About this page

This page shows SINOTAUPHARMA-B (09941) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect